M. Arnold

427 total citations
7 papers, 362 citations indexed

About

M. Arnold is a scholar working on Molecular Biology, Rheumatology and Pharmacology. According to data from OpenAlex, M. Arnold has authored 7 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Rheumatology and 2 papers in Pharmacology. Recurrent topics in M. Arnold's work include Osteoarthritis Treatment and Mechanisms (3 papers), Bone Metabolism and Diseases (3 papers) and Inflammatory mediators and NSAID effects (2 papers). M. Arnold is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (3 papers), Bone Metabolism and Diseases (3 papers) and Inflammatory mediators and NSAID effects (2 papers). M. Arnold collaborates with scholars based in Switzerland, Denmark and United States. M. Arnold's co-authors include M.A. Karsdal, Claus Christiansen, Kim Henriksen, I. Byrjalsen, M. Azria, B.J. Riis, Markus R. John, B.J. Riis, Edith Lau and Anne‐Christine Bay‐Jensen and has published in prestigious journals such as Annals of the New York Academy of Sciences, Bone and Osteoarthritis and Cartilage.

In The Last Decade

M. Arnold

7 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Arnold Switzerland	7	141	137	91	88	71	7	362
Priyanka Kothari India	14	214 1.5×	86 0.6×	78 0.9×	73 0.8×	70 1.0×	22	373
Tatsuyuki Naruchi Japan	10	104 0.7×	18 0.1×	46 0.5×	23 0.3×	45 0.6×	40	381
Isabel García-Arnandis Spain	5	171 1.2×	143 1.0×	25 0.3×	79 0.9×	23 0.3×	5	324
Yuanyuan Kuang China	10	125 0.9×	55 0.4×	19 0.2×	34 0.4×	11 0.2×	26	278
Farhath Sultana United States	9	132 0.9×	63 0.5×	44 0.5×	16 0.2×	17 0.2×	12	259
Jennifer McComb United States	5	94 0.7×	164 1.2×	64 0.7×	68 0.8×	11 0.2×	7	352
Christian Patry Germany	10	123 0.9×	33 0.2×	61 0.7×	118 1.3×	11 0.2×	25	333
Hiroshi Takatsuna Japan	8	168 1.2×	19 0.1×	99 1.1×	45 0.5×	15 0.2×	11	336
Yin-Yu Shi China	6	243 1.7×	60 0.4×	48 0.5×	49 0.6×	64 0.9×	20	378
Ned B. Smith United States	9	95 0.7×	10 0.1×	63 0.7×	11 0.1×	16 0.2×	12	347

Countries citing papers authored by M. Arnold

Since Specialization

Citations

This map shows the geographic impact of M. Arnold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Arnold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Arnold more than expected).

Fields of papers citing papers by M. Arnold

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Arnold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Arnold. The network helps show where M. Arnold may publish in the future.

Co-authorship network of co-authors of M. Arnold

This figure shows the co-authorship network connecting the top 25 collaborators of M. Arnold. A scholar is included among the top collaborators of M. Arnold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Arnold. M. Arnold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Mindeholm, Linda, Aino Launonen, Beate Kiese, et al.. (2012). The single dose pharmacokinetic profile of a novel oral human parathyroid hormone formulation in healthy postmenopausal women. Bone. 50(4). 965–973. 37 indexed citations

2.

Karsdal, M.A., Peter Alexandersen, Markus R. John, et al.. (2011). 64 ORAL CALCITONIN DEMONSTRATED SYMPTOM-MODIFYING EFFICACY AND INCREASED CARTILAGE VOLUME: RESULTS FROM A 2-YEAR PHASE 3 TRIAL IN PATIENTS WITH OSTEOARTHRITIS OF THE KNEE. Osteoarthritis and Cartilage. 19. S35–S35. 15 indexed citations

3.

Karsdal, M.A., Kim Henriksen, Anne‐Christine Bay‐Jensen, et al.. (2010). Lessons Learned From the Development of Oral Calcitonin: The First Tablet Formulation of a Protein in Phase III Clinical Trials. The Journal of Clinical Pharmacology. 51(4). 460–471. 77 indexed citations

4.

Karsdal, M.A., I. Byrjalsen, M. Azria, et al.. (2009). Influence of food intake on the bioavailability and efficacy of oral calcitonin. British Journal of Clinical Pharmacology. 67(4). 413–420. 33 indexed citations

5.

Karsdal, M.A., I. Byrjalsen, Kim Henriksen, et al.. (2009). The effect of oral salmon calcitonin delivered with 5-CNAC on bone and cartilage degradation in osteoarthritic patients: a 14-day randomized study. Osteoarthritis and Cartilage. 18(2). 150–159. 82 indexed citations

6.

Karsdal, M.A., Kim Henriksen, M. Arnold, & Claus Christiansen. (2008). Calcitonin ??? A Drug of the Past or for the Future?. BioDrugs. 22(3). 137–144. 63 indexed citations

7.

Karsdal, M.A., et al.. (2007). Calcitonin Affects Both Bone and Cartilage. Annals of the New York Academy of Sciences. 1117(1). 181–195. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact